Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03BZS
|
|||
Former ID |
DIB015480
|
|||
Drug Name |
MK-8655
|
|||
Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 1 | [1] | |
Company |
Merck
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01640873) Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002 AM1). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.